https://medbridge.global/blog Insights, clinical perspective, and honest conversation from the MedBridge Global faculty. en https://medbridge.global/blog/testosterone-menopause-fda-workshop https://medbridge.global/blog/testosterone-menopause-fda-workshop Wed, 23 Sep 2026 00:00:00 GMT The FDA convened a workshop on testosterone therapy in menopausal women, where one UK clinic's real-world data took center stage. Here's what clinicians should take from it. Menopause Hormone Therapy Women's Health FDA Regulation https://medbridge.global/blog/what-s-next-for-compounded-peptides-q-a-with-nate-hill https://medbridge.global/blog/what-s-next-for-compounded-peptides-q-a-with-nate-hill Sun, 06 Sep 2026 00:00:00 GMT Nate Hill of Strive Pharmacy on FDA Category 1, GMP-vetted API sourcing, and how compounding pharmacies are preparing for the next phase of peptide regulation. Peptide Therapy FDA Regulation Compounding Pharmacy Q&A https://medbridge.global/blog/put-down-the-pom-poms https://medbridge.global/blog/put-down-the-pom-poms Fri, 10 Jul 2026 00:00:00 GMT On bandwagons, MLM energy, "not for human use" experts, and the incredibly powerful science that deserves better than what social media is doing to it. Peptide Therapy Opinion Patient Safety Clinical Education